Eupraxia Pharmaceuticals Inc
(EPRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 33,101 | 19,342 | 18,263 |
| Receivables | 229 | 191 | 90 |
| TOTAL | $34,437 | $19,803 | $18,589 |
| Non-Current Assets | |||
| PPE Net | 358 | 410 | 444 |
| Other Non-Current Assets | 148 | 54 | 90 |
| TOTAL | $506 | $463 | $533 |
| Total Assets | $34,942 | $20,266 | $19,122 |
| Liabilities | |||
| Current Liabilities | |||
| Short Term Debt | N/A | 10,399 | 79 |
| Accounts payable and accrued liabilities | 3,032 | 8,922 | 2,929 |
| TOTAL | $3,103 | $19,374 | $3,058 |
| Non-Current Liabilities | |||
| Long Term Debt | N/A | N/A | 63 |
| Other Non-Current Liabilities | 242 | 745 | 9,243 |
| TOTAL | $N/A | $N/A | $8,856 |
| Total Liabilities | $3,103 | $19,374 | $11,914 |
| Shareholders' Equity | |||
| Shares Outstanding, K | 35,642 | N/A | N/A |
| Common Shares | 116,360 | 92,914 | 71,003 |
| Retained earnings | -131,004 | -105,501 | -77,281 |
| Other shareholders' equity | -5,726 | -4,031 | -3,365 |
| TOTAL | $31,839 | $892 | $7,208 |
| Total Liabilities And Equity | $34,942 | $20,266 | $19,122 |